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Peptidotriazolamers are hybrid foldamers with features of peptides and triazolamers,
containing alternation of amide bonds and 1,4-disubstituted 1H-1,2,3-triazoles with
conservation of the amino acid side chains. We report on the synthesis of a
new class of peptidomimetics, containing 1,4-disubstituted 1H-1,2,3-triazoles in
alternation with amide bonds and the elucidation of their conformational properties
in solution. Based on enantiomerically pure propargylamines bearing the stereogenic
center in the propargylic position and α-azido esters, building blocks were obtained
by copper-catalyzed azide-alkyne cycloaddition. With these building blocks the
peptidotriazolamers were readily available by solution phase synthesis. A panel
of homo- and heterochiral tetramers, hexamers, and heptamers was synthesized
and the heptamer Boc-Ala-Val-Ψ [4Tz]Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll as well
as an heterochiral and a Gly-containing equivalent were structurally characterized
by NMR-based molecular dynamics simulations using a specifically tailored force
field to determine their conformational and solvation properties. All three variants
adopt a compact folded conformation in DMSO as well as in water. In addition
to the heptamers we predicted the conformational behavior of similar longer
oligomers i.e., Boc-Ala-(AlaΨ [4Tz]Ala)6-OAll as well as Boc-Ala-(D-AlaΨ [4Tz]Ala)6-OAll
and Boc-Ala-(GlyΨ [4Tz]Ala)6-OAll. Our calculations predict a clear secondary structure of
the first two molecules in DMSO that collapses in water due to the hydrophobic character
of the side chains. The homochiral compound folds into a regular helical structure and
the heterochiral one shows a twisted “S”-shape, while the Gly variant exhibits no clear
secondary structure.
Keywords: peptidotriazolamers, 1, 4-disubstituted 1H-1, 2, 3-triazole, peptide bond isoster, foldamer, molecular
dynamic simulations
INTRODUCTION
Since the discovery of the CuI catalyzed azide-alkyne cycloaddition (CuAAC) by the
groups of Meldal (Tornøe et al., 2002) and Sharpless (Rostovtsev et al., 2002), this
so-called “click”-reaction proved to be suitable for a broad number of applications in
bioorganic and pharmaceutical chemistry (Kolb and Sharpless, 2003; Bock et al., 2006a;
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Angell and Burgess, 2007; Gil et al., 2007; Moses andMoorhouse,
2007; Hein et al., 2008; Tron et al., 2008; Nwe and Brechbiel,
2009) The CuAAC is compatible with most functional groups
present in biomolecules and the 1,4-disubstituted 1H-1,2,3-
triazole obtained as reaction product is metabolically inert (Kolb
and Sharpless, 2003). Size and dipole moment of the 1,4-
disubstituted triazole ring are larger compared to a trans-amide
bond (Kolb and Sharpless, 2003), but overall physicochemical
properties are similar enough to enable these triazoles to act as
trans-amide mimetics (Figure 1; Brik et al., 2003, 2005; Horne
et al., 2004, 2009; Angell and Burgess, 2005, 2007; vanMaarseveen
et al., 2005; Bock et al., 2006b, 2007;Wang et al., 2006; Appendino
et al., 2007; Kim et al., 2007; Lee et al., 2007; Beierle et al., 2009).
In 2005 the counterpart of the CuAAC, the ruthenium(II)-
catalyzed azide-alkyne-cycloaddition (RuAAC), yielding
selectively 1,5-disubstitued 1H-1,2,3-triazoles, was presented
by Zhang et al. (2005). The latter can act as cis-amide mimetic
(Figure 1; Zhang et al., 2005; Pedersen and Abell, 2011).
Several amide bonds within biologically active substances
have already been replaced by triazoles. The bio-isosterism
has been exemplified by triazole analogs of a matrix
metalloprotease inhibitor (Wang et al., 2006), of the immune-
stimulating natural compound α-galactosylceramide (Kim
et al., 2007; Lee et al., 2007), and of capsaicin in its role as
agonist of the vanilloid-receptor TRPV1 (Appendino et al.,
2007). Small bivalent peptidomimetics based on triazole
formation from amino acid-derived propargylamines and
amino acid-derived α-azido acids were shown to adopt turn-
like conformations and serve as ligands for the receptor
TrkC (Chen et al., 2009).
Further examples are triazole analogs of the peptidic
tyrosinase inhibitor cyclo-[Pro-Tyr-Pro-Val] (Bock et al., 2006b,
2007), of the histone deacetylase inhibitor apicidin (Horne
et al., 2009), the antimitotic cyclodepsipeptide cryptophycin
(Nahrwold et al., 2010) and of peptides containing the
pharmacophoric residues of somatostatin (Beierle et al., 2009).
Moreover, X-ray crystal structure analysis revealed that the
triazole ring within an analog of the HIV-1-protease inhibitor
amprenavir interacts with the enzyme in the same way as an
amide bond in the parent compound (Brik et al., 2003, 2005).
Recently Ben Haj Salah et al. gave a good overview on the topic
of substituting single or isolated amide moieties by 1H-1,2,3-
triazoles and showed the influence of isolated triazole-amide-
bond substitution as well as two cases with multiple substitutions
containing a motif of two triazole replacements separated by
one amide bond in two antimicrobial peptides with helical
conformations (Ben Haj Salah et al., 2018).
Triazolamers, oligomers of 1,4-disubstituted triazoles connect
a series of triazole rings by single C1 unit that, at the same
time, is a stereogenic center (Angelo and Arora, 2005, 2007;
Jochim et al., 2009). The CuAAC can be performed either
in solution or on solid phase to provide the 1,4-disubsituted
triazoles. Best results are obtained in a sequential protocol
when using triflic azide and Cu(II) for the diazo transfer,
where the copper was subsequently reduced by ascorbate to
bring about the CuAAC (Figure 2; Angelo and Arora, 2005;
Beckmann and Wittmann, 2007).
FIGURE 1 | Comparison of a native peptide bond with 1H-1,2,3-triazoles as
amide bond isoster.
Since the triazole ring is characterized by a large dipole
moment it might stabilize discrete conformations by
dipole-dipole interactions. The Arora group investigated
relatively short oligomers and found out that they are likely
to adopt a zigzag conformation reminiscent of β-strands
found in peptides. Indeed, the dipole-dipole-interaction of
neighboring triazole moieties seems to crucially influence the
overall conformation in polar solvents (Angelo and Arora, 2005).
The zigzag triazolamer structure also resembles the
oligopyrrolinones described by Smith and Hirschmann (Smith
et al., 1992). The axial Cβ to Cβ distance between the i and i+2
side chain residues in peptide β-strands is 7.2 Å; this distance is
roughly 7.9 Å in the zigzag triazolamer. The Cβ to Cβ distances
in adjacent residues are 5.5 Å in peptide β-strands and a little
longer (6.8 Å) in the triazolamer (Angelo and Arora, 2005).
In addition, the group of L. Mindt investigated besides
the substitution of isolated peptide bonds by 1,4-disubstituted
triazoles also the replacement of multiple adjacent peptide
bonds attempting to improve the tumor targeting qualities of
bombesin, an amphibious analog of the gastrin releasing peptide
(Valverde et al., 2015).
Peptidotriazole foldamers represent repetitive hybrid
structures of peptides, where e.g., every second amide bond is
being replaced by a triazole. Such short triazole-based peptide
analogs have been obtained from achiral propargylamines and
α-amino acid derived α-azido carboxylic acids (Figure 3, left).
They were found to self-dimerize and act as organogelators
(Ke et al., 2012).
In a similar fashion, the Hecht group synthesized bifunctional
monomers from amino acid-derived α-azido acids and
propargylamine for “click”-polyaddition (Figure 3, right;
Hartwig and Hecht, 2010).
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FIGURE 2 | Solution phase synthesis of triazolamers according to Angelo and Arora (2005).
FIGURE 3 | Triazole-based peptidomimetic with unsubstituted propargylamines (left) and “Click”-polyaddition oligomer; bifunctional monomers from amino
acid-derived α-azido acids and unsubstituted propargylamine (right).
In accordance with recommendations for nomenclature of
amide bond replacements we will use Ψ [4Tz] in this publication
as a placeholder of a 1,4-disubstituted 1H-1,2,3-triazole–i.e., a
dipeptide H-Xaa-Yaa-OH is replaced by H-XaaΨ [4Tz]Yaa-OH.
In a similar fashion Ψ [5Tz] stands for a 1,5-disubstituted 1H-
1,2,3-triazole replacement in the same orientation.
Recently we published on 1,5-disubstituted 1,2,3-triazole
containing peptidotriazolamers (Kracker et al., 2018). Beside the
robust synthetic route it was shown that the homochiral and
heterochiral oligomers adopt versatile foldamer conformations.
Furthermore, the solid state conformation of the homochiral
tetramer Boc-ValΨ [5Tz]Ala-LeuΨ [5Tz]Val-OBzl was in an
excellent agreement with an in silico conformational analysis,
which was performed using a specifically truncated TZLff
molecular mechanics force-field parametrization for 1,4- and 1,5-
disubstituted peptidotriazolamers that we recently established
(Marion et al., 2018).
For the synthesis of the chiral propargylamines, we used
the methodology previously described by Ellman et al. using
(R)- or (S)-tert-butylsulfinamide as a chiral auxiliary (Patterson
and Ellman, 2006). According to the protocol of Ellman et al.
the chiral tert-butylsulfinamide is prepared by enantioselective
oxidation of di-tert-butyl disulfide with a chiral catalyst, followed
by reaction with lithiumamide (Weix and Ellman, 2005).
After formation of the imine using the auxiliary and an
aldehyde as starting material, the diastereoselective synthesis
of propargylamines is possible by reaction of the N-sulfinyl
imine with lithium trimethylsilylacetylide (Wünsch et al., 2017).
Cleavage of the trimethylsilyl protecting group is achieved with
TBAF or AgNO3 to provide the N-sulfinylpropargylamines
with a terminal alkyne moiety. Numerous tert-butylsulfinyl
protected propargylamines [(S)- or (R)-Bus-Xaa≡CH] have
been prepared in our group, bearing natural amino acid
side chains as well as non-amino acid like side chains
(Figure 4; Wünsch et al., 2017).
RESULTS AND DISCUSSION
Synthesis
Inspired by the Arora triazolamers, we embarked on a
project directed toward the synthesis and characterization
of peptidotriazole foldamers, where both components, the
propargylamine and the α-azido carboxylic acids are chiral. The
chiral propargylamines were synthesized via the Ellman strategy
and the α-azidocarboxylic acids from commercially available
α-amino acids by diazotransfer (Yan et al., 2005). Several α-
azidocarboxylic acids as well as the corresponding amino acid
allyl esters can be synthesized under mild reaction conditions
with good to very good yields.
In principle, there are two strategies for the synthesis
of peptidotriazole foldamers: the building block approach
(Figure 5), where the triazole is formed from the propargylamine
and the azide by CuAAC and then coupled by amide bond
formation, and the submonomer approach (Figure 5), where first
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FIGURE 4 | Synthesis of diasteromerically pure N-sulfinyl propargylamines,
used for the oligomers of this publication.
FIGURE 5 | Building block and submonomer approach. Stereogenic centers
are labeld with an asterisk.
the α-azido carboxylic acid is coupled and then the N-protected
propargylamine is reacted by CuAAC.
In the case of activation of the free acid of the triazole-
building block 4 (Val side chain), epimerization was observed
even upon using TBTU/HOBt/DIPEA or HATU/HOAt/DIPEA
as the coupling reagents. Therefore, the submonomer approach
was initially chosen for the synthesis of the peptidotriazole
foldamers. In this case the α-azido carboxylic acid can be
activated with e.g., HATU/HOAt without any epimerization.
Eventually it has been shown, that a carbodiimide-mediated
preactivation in DCM, without the use of a base, and subsequent
coupling with the use of 2,4,6-collidine, effectively prevents
epimerization during the coupling of the free acid of the
triazole-building block 4 (Kracker et al., 2018). K Ben Haj Salah
et al. also used the building block approach for their synthesis
of peptaibols analogs containing AibΨ [4Tz]-Xaa dipeptides
(Ben Haj Salah et al., 2015).
The C-terminal component was protected as allyl ester and
the propargylamines were employed as sulfinamide as well as
Boc protected derivatives. The tert-butylsulfinyl group (Bus)
is acid-labile and can be cleaved e.g., by treatment with 4M
HCl in dioxane at room temperature. In addition, it was
reported to be cleavable with 50% trifluoroacetic acid in CH2Cl2
(Lee and Silverman, 2000).
An example of the peptidotriazole foldamer synthesis
is given in Figure 6. Triazole formation was achieved
by CuAAC in the presence of 0.5 eq. of CuSO4·5 H2O
and 1 eq. sodium ascorbate in DMF/water mixtures.
Lower amounts of copper salt and reductant led to
incomplete conversion, as had been previously observed by
others (Angelo and Arora, 2005).
Several homo- (7a, 9a, 10a) and heterochiral (7b, 9b,
10b) peptidotriazole foldamers as well as one where
every second amino acid side chain is exchanged by
a hydrogen atom (7c, 9c, 10c), have been obtained
(Figure 7). Some peptidotriazole foldamers with N-
terminal Bus group that had been purified by HPLC with
an acetonitrile/water/TFA gradient slowly decomposed in
DMSO solution upon standing. Notably, this instability
also depends on the sequence. After cleavage of the
Bus group and acylation e.g., with Boc-Ala the resulting
heptamers were completely stable. The tert-butylsulfinyl
group had been suggested as a substitute for the Boc
group. However, its stability, in particular at elevated
temperatures, is not sufficient to qualify Bus as a versatile
protecting group. According to the rearrangement suggested
for the Ellman auxiliary by Arava et al. (2011) we found
out that a fragment (S) or (R)-BusXaaΨ [4Tz]Yaa-OAll
rearranges with a second equivalent to form (S) or (R)-
H-XaaΨ [4Tz]Yaa-OAll and (tert-Bu-SO2)(tert-Bu-S)Xaa
Ψ [4Tz]Yaa-OAll.
Conformational Analysis
We analyzed the conformational preferences of 1,4-disubstituted
peptidotriazolamers in solution by means of CD spectroscopy
and molecular dynamics (MD) simulations based on the
specific molecular mechanics force-field parameterization TZLff
(Marion et al., 2018). As representative molecules, we selected
compounds 10a, 10b, and 10c (further referred to as homochiral,
heterochiral, and homochiral∗, respectively) to investigate the
effect of chirality and of the introduction of glycine-like
moieties on the conformational preferences of the peptide
mimetics. Schematic representations of the three molecules
are given in Figure 8. Therein, we additionally indicate our
definition for the backbone conformational degrees of freedom
for peptidotriazolamers as the φ and ψ torsion angles. In the
following, φ and ψ notations are used indifferently whether it
refers to a standard amino acid or to a triazole-based derivative
(Marion et al., 2018).
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FIGURE 6 | Synthesis of the homochiral peptidotriazole Boc-Ala-ValΨ [4Tz]Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll (10a). a) CuSO4·5H2O, sodium ascorbate,
H2O/DMF, RT, 15 h; b) 4M HCl in dioxane, MeOH, RT, 2 h; c) N2=Phe-OH, HATU, HOAt, DIPEA, DMF, RT, 15 h; d) (S)-Bus-Leu-CH, CuSO4·5H2O, sodium
ascorbate, H2O/DMF, RT, 15 h; e) 4M HCl in dioxane, MeOH, RT, 2 h; f) N2=Phe-OH, HATU, HOAt, DIPEA, DMF, RT, 15 h; g) (S)-Bus-Val-CH, CuSO4·5H2O, sodium
ascorbate, H2O/DMF, RT, 15 h; h) 4M HCl in dioxane, MeOH, RT, 2 h; i) Boc-Ala-OH, HATU, HOAt, DIPEA, DMF, RT, 15 h.
CD Spectroscopy
CD spectra were recorded to get a first experimental insight into
the conformational properties of the three oligomer types. It
should be emphasized that the solvent used for themeasurements
is acetonitrile since DMSO is not applicable due to its strong
absorbance below 270 nm. It becomes clear (Figure 9) that the
different types of peptidotriazole heptamers have characteristic
CD signatures. The heterochiral compound 10b has a positive
CD below 210 nm, while the CD remains negative for the
homochiral all-(S)-configured 10a. The CD spectrum of 10c is
somewhat intermediate, with a sign inversion at about 202 nm.
Molecular Dynamics
For each of the three representative molecules (10a-c), we
performed one simulation in DMSO (i.e., the solvent used
for NMR measurements) and one simulation in water, as
representative of a more biologically relevant environment. The
simulations in solution were started using an initial structure
derived from an extensive, simulated annealing-based sampling
in gas phase during which NMR-derived interproton distance
restraints were applied (see section Methodology for details).
Monitoring of the backbone root mean square deviations
(RMSD) along the trajectories of each molecule showed that
most compounds adopt one main stable conformation in
both solvents, with standard deviations ranging from 0.18 to
0.79 Å over the whole trajectory for all six MD trajectories
(Supplementary Figure 10). Repetitive bumps in the RMSD time
series of 10c in water show that the molecules adopt at least
two stable conformations in water and that our MD simulations
sampled them appropriately. Radius of gyration (ROG) time
series indicate similar results for all compounds with mean
values ranging from 3.5 to 4.0 Å with minor amplitudes of
fluctuations after 100 ns (Supplementary Figure 11). Such small
values for the ROG of the 1,4-disubstituted peptidotriazolamers
are indicative for a compact folded conformation for all three
variants. All the time series indicate that the simulations reached
convergence after 100 ns at most. We therefore considered the
last 100 ns as converged and used this part in each simulation for
the following analysis.
The distribution of φ/ψ backbone torsional degrees of
freedom is depicted in Figure 10 for each molecule in
both solvents. Although the plots resemble Ramachandran
distributions, a direct comparison with known patterns for
standard peptides is not straightforward due to the introduction
of the triazole moieties in the sequence. Nevertheless, the plots
give a qualitative picture of the differences and similarities
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FIGURE 7 | Homo- and heterochiral peptidotriazole tetramers, hexamers, and heptamers.
between the three variants considered in this analysis and
of the effect of the solvent polarity on their conformational
preferences. Overall, all three molecules appear to have their own
unique signature in terms of distribution of backbone torsion
angles. While distribution maxima depict distinct patterns
for homo- and heterochiral, the glycine-containing derivative
(homochiral∗) shows features of both parent oligomers. The
polarity of the solvent appears to have little to no effect on the
φ/ψ distribution for all three molecules.
Clustering based on the backbone RMSD of the oligomers
for the second half of the simulations in DMSO and in water
resulted in the following populations for the main structural
clusters: 94 and 52% for the homochiral molecule in DMSO
and in water, respectively, 71 and 59% for the heterochiral,
and 60 and 76% for the homochiral∗ compound. For the
heterochiral compound in water, a second structural cluster
was found with a population of 40% that differed from the
main representative structure with a backbone RMSD value
of 0.54 Å. The differences were localized on the flexible
terminal residues and both structures can, therefore, be formally
assigned to the same conformation with a total population
of 99%, as confirmed by the rather flat RMSD and radius of
gyration time-series (Supplementary Figures 10, 11). Similarly,
the homochiral∗ variant in DMSO results in a second main
cluster with a trajectory fraction of 21% and a backbone
RMSD value of 0.81 Å, primarily caused by both flexible ends
pointing in orthogonal direction. Thus, the two main clusters
can be joined with a combined trajectory fraction of 81%.
Such large populations are consistent with the rigid character
of the peptidomimetics already observed from the RMSD time
series. To a given extent, the homochiral∗ molecule appears
to be slightly more flexible than the others when plunged in
water. The representative structure for the main cluster of each
simulation is depicted in the upper panel of Figure 11. In general,
all oligomers considered in this analysis fold with a helically
twisted conformation. Consistently with our observations thus
far, the solvent has little to no effect on the conformation of
the oligomers. The values of backbone torsional angles for the
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FIGURE 8 | Homo- and heterochiral peptidotriazolamers as representatives for in silico structure determination. The definition for the torsion angles φ and ψ for these
peptidomimetic torsions is annotated by the colored bonds.
FIGURE 9 | CD Spectra for the homochiral (10a), the heterochiral (10b), and
the homochiral* (10c) oligomers measured at 20◦C at a concentration of
125µM in acetonitrile.
representative structure in DMSO and in water are listed in
Table 1. The lower panel of Figure 11 shows a direct comparison
of the backbone of the homochiral and homochiral∗ variants,
the heterochiral and homochiral∗ ones, as well as a comparison
between homo- and heterochiral ones. The figure illustrates
that the homochiral and homochiral∗ compounds fold into a
nearly identical conformation in DMSO and in water, while the
heterochiral molecule adopts a slightly different orientation of
the triazole rings in DMSO and a significantly yet still compact
conformation in water. Taking the homochiral molecule as
reference, the homochiral∗ and heterochiral compounds have a
backbone RMSD value of 0.45 and 1.97 in DMSO, respectively,
and of 1.27 and 3.61 Å in water.
We further analyzed the potential solvation properties
of the three oligomers in water by calculating the radial
distribution functions (RDF) around key chemical groups.
The complete results are available as supporting information
(Supplementary Figures 12–14). In general, the RDFs show that
the molecules are poorly solvated in water, which is expected
regarding the highly hydrophobic character of the side chains.
Only specific groups such as the backbone carbonyl moiety
show stable interactions with one water molecule over the whole
simulation with distances characteristic of hydrogen bonds. Such
interactions are conserved over all three molecules, as illustrated
by the RDF for the carbonyl group of the first alanine amino
acid in Figure 12. Therein, we observe a sharp peak at about
1.8 Å, but no further structure formation at larger distances
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FIGURE 10 | φ/ψ torsion angle distribution of the three representative molecules (homochiral: 10a, heterochiral: 10b, homochiral*: 10c) for the last 100 ns of MD in
DMSO (first row) and TIP4Pew water (second row).
due to the hydrophobic character of the rest of the molecule.
Among all the potential hydrogen bond donor/acceptor groups
in the peptidomimetic considered in this work, we noted only
few significant differences. (i) A shallow peak is present at short
distances in the RDF of the nitrogen atom (N3) of the first triazole
ring for both the homochiral and the homochiral∗ molecules.
The integration of this peak returns a value corresponding to a
sporadic interaction with a water molecule occurring for about a
third of the simulation time only. This weak interaction, however,
is totally absent in the case of the heterochiral compound. (ii)
Similar observations can be made regarding the hydrogen of
that same triazole ring, which is involved in a weak interaction
with water in two of the three molecules. As opposed to (i),
however, this interaction is absent for the homochiral molecule
and present for the two others. We also notice that, considering
the sharpness of the peak, this interaction is tighter in the case
of the heterochiral molecules than it is for the homochiral∗ one.
(iii) Comparison of the RDF around the amide nitrogen of the
8th residue (i.e., Leu or Gly) indicates that this site is slightly
more solvent accessible in the case of the heterochiral compound
than it is for the two other molecules. These differences are due
to a slightly better orientation of the corresponding chemical
groups favoring interactions with the solvent and potentially
with other polar compounds in different environments. Although
these interactions with water are somewhat weak for these
oligomers, the differences that we observed are indicative of
potential interaction sites that could discriminate one molecule
from another in a hypothetical protein environment.
Overall our conformational analysis revealed only little
differences between the three variants of the oligomers under
investigation. All three adopt a compact folded conformation
in DMSO. The homochiral compound (10a) and the glycine
containing analog (10c) adopt nearly identical conformations
in DMSO, which tends to correlate with the observation of
a similar pattern on the CD spectra for these two molecules.
Considering the high hydrophobic character of the side chains,
it is not surprising that the molecules remain folded in water
in order to minimize the interaction surface area with the polar
environment. This observation that the chirality of the different
stereocenters has no significant impact on the conformation
of the 1,4-disubstituted peptidotriazolamers is in contrast with
our results for the 1,5-disubstituted counterpart (Kracker et al.,
2018). There we identified that changes in the chirality of the
α-carbons can induce drastic changes in the conformation of
the molecules, i.e., while the homochiral hexapeptidotriazolamer
Boc-AlaΨ [5Tz]Phe-ValΨ [5Tz]Ala-Leu-Ψ [5Tz]Val-OBzl formed
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FIGURE 11 | Upper panel: Representative structures for the main cluster of the three representative molecules (10a-c, homochiral, heterochiral, homochiral*) as
obtained from backbone RMSD-based clustering over the last 100 ns of molecular dynamics in DMSO (orange) and TIP4Pew Water (iceblue). Lower panel:
Alignment of the representative structure backbones for the homochiral and homochiral*, the heterochiral and homochiral*, as well as homo- and heterochiral
oligomer. The homochiral oligomer is colored in yellow (DMSO) and cyan (Water), respectively, the heterochiral in red (DMSO) and blue (Water), respectively and the
homochiral* in orange (DMSO) and purple (Water), respectively.
a compact β-turn-like structure, the heterochiral equivalent
was observed and predicted in an extended polyproline I-like
conformation (Ke et al., 2012).
To further characterize the conformational properties of
1,4-disubstituted peptidotriazolamers, we analyzed a longer,
hypothetical oligomer bearing only methyl side chains to mimic
a poly-alanine peptide Figure 8). Similarly, to the case of shorter
molecules, we considered three variants labeled as homochiral,
heterochiral, and homochiral∗. Due to the significantly larger
conformational space of these oligomers, we performed four
parallel 200 ns simulations for each molecule in each of the two
solvents (i.e., in DMSO and in water, for a total of 24 simulations)
in order to reach a statistically significant sampling.
The RMSD time series for the whole trajectory of each
replicate simulation are shown in Figure 13. As expected,
the simulations took longer to reach their local equilibrium
compared to the case of the smaller molecules. After 150 ns, all
trajectories reach a stable value of RMSD or oscillate between
two conformational basins in a balanced manner. Compared to
the case of shorter oligomers in which we had NMR information
to produce relevant initial structures, the lack of experimental
data in the present case translates into higher RMSD values
since our initial geometries are likely to be far from a minimum
conformation. Nevertheless, all simulations reached equilibrium
and yield a distribution of stable conformers.
In contrast to the case of short oligomers, the homo- and
heterochiral polyalanine derivatives suffer from a significant
decrease of flexibility when moving from DMSO to water.
This is illustrated in Figure 13 by the fact that all four
simulations systematically converge toward the same value of
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TABLE 1 | Dihedral angles of the representative structures for the main cluster of
the three representative molecules (10a-c, homochiral, heterochiral, homochiral*)
as obtained from molecular dynamics in DMSO and TIP4Pew Water.
Homochiral Heterochiral Homochiral*
8 9 8 9 8 9
DMSO
Ala1 −61.9 132.4 −64.3 1.1 −78.8 158.2
V/G4n2 −148.7 −176.8 143.2 −169.5 −146.2 −170.3
F4c4 −58.6 −13.8 72.2 39.2 −58.2 2.8
L/G4n5 −117.6 −148.0 132.9 −163.6 −156.9 −142.0
F4c7 62.3 3.1 75.8 24.8 72.9 24.1
L/G4n8 −168.7 −171.1 142.8 −175.4 154.2 −166.1
V4c10 57.0 3.4 65.0 −13.3 62.1 0.0
WATER
Ala1 −67.0 131.8 −97.4 19.5 −133.1 15.5
V/G4n2 −136.4 −112.8 167.0 −168.5 −130.4 165.5
F4c4 75.7 1.5 64.6 39.4 −67.1 22.5
L/G4n5 −155.0 175.3 131.4 −48.1 172.3 −153.7
F4c7 68.2 −3.8 71.6 37.5 65.0 37.4
L/G4n8 −152.0 −168.6 125.1 168.7 131.5 −153.5
V4c10 51.5 3.9 −51.1 −34.1 83.9 −15.2
RMSD in water only. Once this stable plateau is reached,
the amplitude of fluctuations also decreases, showing the tight
conformational restraints exerted by the solvent on the solute.
Such a drastic effect of the solvent was, however, not observed
in the case of the glycine-containing variant (homochiral∗),
which is most likely due to the significantly reduced hydrophobic
character of that molecule. ROG time series are available
as supporting information (Supplementary Figure 15) for the
whole trajectories and show that even significant fluctuations
in RMSD do not result in large changes in the compactness
of the conformations. The φ/ψ torsion angle distributions
(Supplementary Figure 16) are in a good agreement with the
RMSD fluctuations, showing that all three molecules have a
unique conformational signature.
We performed the clustering analysis over the last 50 ns
of the trajectories of all four replica. The main structural
clusters in DMSO and water showed a population of 55 and
95%, respectively for the homochiral, 72 and 91% for the
heterochiral, and 52 and 40% for the homochiral∗ oligomer.
For the homochiral∗ molecule in water three other clusters with
significant population (i.e., 32 and 27%) were identified, but
showing a high similarity with the main cluster as indicated by
backbone RMSD values as low as 1.4 and 0.8 Å.
The representative structures are shown in Figure 14. The
homochiral molecule shows a clear helical conformation in
DMSO, which collapses in water. The heterochiral molecule
shows a compactness in DMSO similar to that of the homochiral
one. However, the conformation of the former describes a twisted
“S”-shape, which also collapses in water. The Gly-substituted
oligomer shows no clear secondary structure in either of the
solvents, which is in agreement with the more flexible character
of this molecule as interpreted from the RMSD time series.
FIGURE 12 | Radial distribution functions of selected interactions for the
homochiral, the heterochiral, and the homochiral* oligomers (10a-c,
homochiral, heterochiral, homochiral*) in TIP4Pew water.
CONCLUSION
Herein we present a new class of peptidomimetics containing
1,4-disubstituted 1H-1,2,3-triazoles and amide bonds in
an alternating fashion. The synthesis is based on chiral
propargylamines and chiral α-azido acids. Beside the
introduction of a versatile and robust synthetic strategy
we elucidated their foldamer properties by means of molecular
dynamics simulations in explicit solvent. Homo- and heterochiral
tetra-, hexa-, and heptamers based on two different sequences
as well as a homochiral oligomer, in which every second
sidechain is replaced by a proton, have been synthesized
based on a submonomer approach. Molecular modeling of the
Boc-Ala-ValΨ [4Tz]Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll
sequence (homo- and heterochiral) as well as a Gly-substituted
derivative revealed a compact folded conformation in DMSO,
similar for all three variants. The conformation of these
molecules remains compactly folded in water as well, due to the
hydrophobic character of the non-polar side chains. In addition,
we predicted the conformations of homo-, heterochiral, and
glycine-containing poly-alanine peptidotriazole oligomers. In
contrast to the shorter oligomers, our calculations suggest a
well-defined and significantly different secondary structure
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FIGURE 13 | RMSD time series for the whole trajectory of homochiral, heterochiral, and homochiral* poly-alanine derivatives in DMSO (first row) and TIP4Pew water
(second row) for Poly-Ala’s homochiral, heterochiral and homochiral* equivalent. The starting point of the trajectory is taken as reference point.
for the homo- (helix) and heterochiral (twisted S) variants
in DMSO, which collapses in water. The glycine-substituted
oligomers, however, shows no clear secondary structure and
a significantly higher flexibility compared to the two other
variants, with a conformational space that is little-affected by the
solvent’s polarity.
EXPERIMENTAL SECTION
Synthesis
All chemicals were purchased from Sigma Aldrich (Taufkirchen,
Germany), Acros (Geel, Belgium), Alfa Aesar (Ward Hill,
USA), VWR (Darmstadt, Germany), Chempur (Karlsruhe,
Germany), Iris Biotech (Marktredwitz, Germany), Bachem
(Bubendorf, Switzerland), and were employed without
additional purification. Moisture- and air-sensitive reaction
steps were conducted in flame-dried glassware and under argon
atmosphere. Dichloromethane and toluene were freshly distilled
from CaH2 and Na, respectively. THF was pre-dried over KOH
followed by drying over sodium/benzophenone under reflux
conditions and was distilled freshly prior usage.
Analytical RP-HPLC was performed on a Thermo Separation
Products system equipped with a UV-6000 LP detector, a P-4000
pump, a Hypersil Gold 3µm (C18; 150 × 2.1mm) column. A
flow rate of 0.7mL min−1 using Eluent A: H2O/CH3CN/TFA
(95/5/0.1) and Eluent B: CH3CN/H2O/TFA (95/5/0.1) was
employed. Method A1: 0–3min (100% A 0% A), 3–4min (0%
A), 4–5min (0% A 100% A). Method A2: 0–0.5min (100% A),
0.5–7.5min (100% A 0% A), 7.5–8.5min (0% A), 8.5–9.5min
(0% A 100% A), 9.5–10min (100% A).
Preparative RP-HPLC was performed on a Hitachi MERCK
LaChrom system equipped with a UV-Vis L-7420 detector, a L-
7150 pump and a Phenomenex Jupiter 10µm column (C18; 300
Å, 250× 21.1mm). A flow rate of 10.0mLmin−1 using Eluent A:
H2O/CH3CN/TFA (95/5/0.1) and Eluent B: CH3CN/H2O/TFA
(95/5/0.1) was employed. Method P1: 0–3min (100% A 75%
A), 3–20min (75% A 0% A), 20–100min (0% A), 100–110min
(0% A 100% A). Method P2: 0–3min (100% A), 3–35min
(100% A 15% A), 35–100min (15% A), 35–100min (15% A),
100–110min (15% A 100% A). Method P3: 0–5min (100% A),
5–35min (100% A 0% A), 35–40min (0% A), 40–45min (0%
A 100% A).
In addition, a Thermo Separation Products system equipped
with a UV-1000 detector, a P-4000 pump, was used utilizing the
same methods.
NMR spectra were recorded at 298K on a DRX 500 (1H: 500
MHz, 13C: 126 MHz), an Avance III 500 (1H: 500 MHz, 13C:
126 MHz), and an Avance 600 spectrometer (1H: 600 MHz, 13C:
151 MHz) (Bruker Biospin, Rheinstetten, Germany). Chemical
shifts are reported relative to residual solvent peaks (DMSO-
d6: 1H: 2.50 ppm, 13C: 39.52 ppm; CDCl3: 1H: 7.26 ppm, 13C:
77.16 ppm) (Gottlieb et al., 1997). 1H- and 13C-NMR spectra
(Supplementary Figures 1–9) as well as 1H-1H-COSY-, 1H-1H-
TOCSY, 1H-13C-HMBC, and 1H-13C-HMQC-NMR spectra were
used for the signal assignments. 1H-1H-ROESY-NMR spectra
were only taken for the restraints list.
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FIGURE 14 | Representative structures for the main cluster of the three representative polyalanine derivatives, as obtained from molecular dynamics in DMSO
(orange) and TIP4Pew Water (iceblue). The clustering was performed over the last 50 ns, based on the backbone atoms (CO, N, Cα, N1, N2, N3) only.
ESI/APCI mass spectra were recorded using an Esquire 3000
ion trap mass spectrometer (Bruker Daltonik GmbH, Bremen,
Germany) equipped with a standard ESI/APCI source. Samples
were introduced directly with a syringe pump. Nitrogen served
both as the nebulizer gas and the dry gas. Nitrogen was generated
using a Bruker nitrogen generator NGM 11. Helium served as
cooling gas for the ion trap and collision gas for MS experiments.
MALDI TOF mass spectra were recorded with a Ultraflex
MALDI-TOF/TOF mass spectrometer (Bruker Daltonik
GmbH, Bremen, Germany) operated in reflectron mode. 2,5-
Dihydroxybenzoic acid was used as the matrix. Ionization was
achieved using a LTB nitrogen laser MNL 200 (337 nm beam
wavelength, 50Hz repetition rate).
High-resolution masses were recorded using a MicroToF
mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany)
with sample-loop injection. Mass calibration was performed
immediately priormeasurement with sodium formate cluster and
quasi-internal calibration.
CD-spectra were recorded on a JASCO J-810 spectrometer in
acetonitrile (HPLC grade) at 20◦C.
General Procedures
Bus-protected propargylamines were synthesized according to
Wünsch et al. (2017) as well as the α-azido acids in the style of
Kracker et al. (2018).
GP-1: The azide (1.1 equivalent) and the alkyne (1.0
equivalent) were dissolved in DMF/H20 (10:1, 0.1M solution).
Afterwards, CuSO4·5H2O (0.5 equivalents) and sodium
ascorbate (1.0 equivalent) are added. The mixture was stirred
15 h at room temperature. After completion of the reaction
the solvent was evaporated. The residue was dissolved with
saturated NaCl-solution. After extraction with DCM (3×),
drying over Na2SO4, and evaporation of the solvent, the pure
triazole was delivered after purification via preparative HPLC or
column chromatography.
GP-2: The free amine was dissolved in DMF (0.1M
solution). After addition of HATU (1.5 equivalents), HOAt (1.5
equivalents), DIPEA (9.0 equivalents) and an azidocarboxylic
acid (1.1 equivalents) the reaction mixture is stirred 15 h at
rt. After evaporation of the solvent purification via preparative
HPLC or column chromatography yields the pure amide.
Explicit Experimental Procedures
(S)-Bus-LeuΨ [4Tz]Val-OAll (3a): N2=Val-OAll (1a, 132mg,
0.720 mmol), (S)-Bus-Leu-CH (2a, 104mg, 0.483 mmol),
CuSO4·5H2O (60mg, 0.24 mmol) and sodium ascorbate (96mg,
0.48 mmol) were stirred according to GP-1. Purification via
column chromatography (DCM/MeOH 80:1, Rf = 0.13) yielded
the product as yellow oil. Yield: 180mg (0.452 mmol, 94%); 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 7.88 (s, 1H); 5.88 (m, 1H);
5.31 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 17.1Hz, 2J = 1.1Hz, 1H);
5.25 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 10.5Hz, 2J = 1.1Hz, 1H);
5.10 (d, 3J = 8.8Hz, 1H); 4.68–4.60 (m, 2H); 4.53 (m, 1H); 3.69
(d, 3J = 8.1Hz, 1H); 2.47 (m, 1H); 1.90–1.77 (m, 2H); 1.68 (m,
1H); 1.19 (s, 9H); 1.00 (d, 3J = 6.7Hz, 3H); 0.91 (d, 3J = 6.7Hz,
3H); 0.89 (d, 3J = 6.6Hz, 3H); 0.83 (d, 3J = 6.8Hz, 3H); 13C-
NMR (126 MHz, CDCl3): δ [ppm] = 168.5; 150.2; 131.0; 121.3;
119.8; 68.9; 66.6; 56.4; 51.4; 45.5; 32.5; 24.6; 22.9; 22.8; 21.9; 19.3;
18.8; MS (ESI):m/z= 421.3 ([M+Na]+); HRMS (ESI):m/z calcd.
for C19H34N4O3SNa+ ([M+Na]+): 421.2244, found: 421.2253.
N2=Phe-LeuΨ [4Tz]Val-OAll (6a): (S)-Bus-LeuΨ [4Tz]Val-
OAll (3a, 171mg, 0.429 mmol) was dissolved in MeOH (4mL).
After addition of 4M HCl in dioxane (2.15mL, 8.6 mmol)
the mixture was stirred for 2 h at rt. After evaporation of the
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solvent the product was used for the next step without further
purification. 1H-NMR (500 MHz, CDCl3): δ [ppm] = 8.53 (s,
3H); 8.09 (s, 1H); 5.89 (m, 1H); 5.33 (dddd, 4J = 1.4Hz, 1.4Hz,
3J = 17.2Hz, 2J = 1.2Hz, 1H); 5.27 (dddd, 4J = 1.2Hz, 1.2Hz, 3J
= 10.3Hz, 2J = 1.0Hz, 1H); 5.14 (d, 3J = 8.5Hz, 1H); 4.71–4.60
(m, 3H); 2.49 (m, 1H); 2.00 (m, 1H); 1.90 (m, 1H); 1.48 (m, 1H);
0.99 (d, 3J = 6.7Hz, 3H); 0.90 (d, 3J = 6.5Hz, 3H); 0.87 (d, 3J =
6.6Hz, 3H); 0.81 (d, 3J = 6.7Hz, 3H).
H-LeuΨ [4Tz]Val-OAll·HCl was stirred with the azido
carboxylic acid N2=Phe-OH (1b, 90mg, 0.47 mmol), HATU
(247mg, 0.650 mmol), HOAt (88mg, 0.65 mmol) and DIPEA
(0.65mL, 3.87 mmol) according toGP-2. Purification via column
chromatography (DCM/MeOH 50:1, Rf = 0.27) yielded the
product as colorless solid. Yield: 181mg (0.387 mmol, 86%);
1H-NMR (500 MHz, CDCl3): δ [ppm] = 7.75 (s, 1H); 7.32–7.25
(m, 5H); 6.80 (d, 3J = 8.7Hz, 1H); 5.89 (m, 1H); 5.33 (dddd, 4J =
1.5Hz, 1.5Hz, 3J = 17.1Hz, 2J = 1.1Hz, 1H); 5.28 (dddd, 4J =
1.5Hz, 1.5Hz, 3J = 10.2Hz, 2J = 1.0Hz, 1H); 5.21 (m, 1H); 5.13
(d, 3J = 8.7Hz, 1H); 4.71–4.62 (m, 2H); 4.18 (dd, 3J = 7.8Hz,
4.2Hz, 1H); 3.32 (dd, 3J = 4.3Hz, 2J = 14.0Hz, 1H); 3.06 (dd,
3J = 8.1Hz, 2J = 14.2Hz, 1H); 2.47 (m, 1H); 1.70–1.67 (m, 2H);
1.34 (m, 1H); 1.02 (d, 3J = 6.7Hz, 3H), 0.89 (d, 3J = 6.6Hz, 3H);
0.88 (d, 3J = 6.5Hz, 3H); 0.82 (d, 3J = 6.7Hz, 3H); 13C-NMR
(126 MHz, CDCl3): δ [ppm] = 168.5; 167.7; 148.2; 136.1; 131.0;
129.7; 128.7; 127.3; 120.8; 119.9; 68.9; 66.6; 65.5; 44.1; 44.0;
38.5; 32.5; 24.7; 22.7; 22.3; 19.3; 18.8; MS (ESI): m/z = 490.2
([M+Na]+’); HRMS (ESI): m/z calcd. for C24H33N7O3Na+
([M+Na]+): 490.2537, found: 490.2542.
(S)-Bus-Leuψ[4Tz]Phe-LeuΨ [4Tz]Val-OAll (7a): N2=Phe-
LeuΨ [4Tz]Val-OAll (6a, 181mg, 0.387 mmol) was stirred
with the alkyne (S)-Bus-Leu-CH (2a, 92mg, 0.43 mmol),
CuSO4·5H2O (50mg, 0.20 mmol) and sodium ascorbate (77mg,
0.39 mmol) according to GP-1. Purification via preparative RP-
HPLC yielded the product as colorless solid. Yield: 155mg (0.227
mmol, 59%); Analytical RP-HPLC(Method A1): tR = 3.49min;
Preparative RP-HPLC(Method P2, 220 nm): tR = 42.0min; 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 7.67 (s, 1H); 7.59 (s, 1H);
7.15–7.14 (m, 3H); 7.06 (d, 3J = 8.4Hz, 1H); 6.99–6.97 (m, 2H);
5.90 (m, 1H); 5.32 (dddd, 4J = 1.2Hz, 1.2Hz, 3J = 17.1Hz, 2J =
1.6Hz, 1H); 5.28 (dddd, 4J = 1.2Hz, 1.2Hz, 3J = 10.3Hz, 2J =
1.2Hz, 1H); 5.26–5.19 (m, 2H) 5.10 (d, 3J = 8.8Hz, l1H); 4.71–
4.61 (m, 2H); 4.46 (m, 1H); 3.88 (m, 1H); 3.56 (dd, 3J = 6.5Hz, 2J
= 14.1Hz, 1H); 3.38 (dd, 3J = 9.2Hz, 2J = 14.1Hz, 1H); 2.47
(m, 1H); 1.86–1.77 (m, 2H); 1.74–1.70 (m, 2H); 1.58 (m, 1H);
1.45 (m, 1H); 1.19 (s, 9H); 1.01 (d, 3J = 6.7Hz, 3H), 0.91 (m,
12H); 0.81 (d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz, CDCl3):
δ [ppm] = 168.4; 166.8; 149.7; 148.2; 135.7; 131.0; 129.1; 128.8;
127.3; 122.7; 121.1; 119.9; 69.0; 66.7; 66.1; 56.5; 51.4; 45.1; 44.6;
43.8; 39.1; 32.5; 24.9; 24.6; 22.8; 22.7; 22.7; 22.2; 21.2; 19.3; 18.8;
MS (ESI): m/z = 705.4 ([M+Na]+); HRMS(ESI): m/z calcd. for
C35H54N8O4SNa+ ([M+Na]+): 705.3881, found: 705.3871.
N2=Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll (8a): (S)-Bus-
LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll (7a, 33mg, 0.048mmol) was
dissolved in MeOH (2mL) and stirred at rt with 4M HCl in
dioxane (24 µL solution). After 2 h the solvent was evaporated.
The free amine was dissolved in DMF and stirred with the azido
carboxylic N2=Phe-OH (1b, 10mg, 0.052 mmol), HATU (28mg,
0.073 mmol), HOAt (10mg, 0.073 mmol) and DIPEA (74 µL,
0.44 mmol) according to GP-2. Purification via preparative RP-
HPLC yielded the product as colorless solid. Yield: 10mg (13
µmol, 27%); Preparative RP-HPLC: tR = 27.2min (Method P1,
220 nm); 1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.94 (d, 3J
= 8.4Hz, 1H); 8.56 (d, 3J = 8.6Hz, 1H); 7.98 (s, 1H); 7.93 (s,
1H); 7.29–7.26 (m, 2H); 7.22–7.21 (m, 3H); 7.17–7.11 (m, 5H);
5.90 (m, 1H); 5.61 (dd, 3J = 9.5Hz, 6.4Hz, 1H); 5.29–5.20 (m,
3H); 5.06–5.01 (m, 2H); 4.70–4.63 (m, 2H); 4.00 (dd, 3J = 9.0Hz,
5.5Hz, 1H); 3.35 (dd, 3J = 6.4Hz, 2J = 14.2Hz, 1H); 3.30 (dd, 3J
= 9.4Hz, 2J = 14.0Hz, 1H); 3.02 (dd, 3J = 5.4Hz, 2J = 13.9Hz,
1H); 2.90 (dd, 3J = 9.0Hz, 2J = 13.9Hz, 1H); 2.57 (m, 1H); 1.73–
1.60 (m, 4H); 1.47–1.37 (m, 2H); 0.96 (d, 3J = 6.7Hz, 3H), 0.88
(m, 6H); 0.83 (d, 3J = 6.6Hz, 3H); 0.72 (m, 6H); 13C-NMR (126
MHz, DMSO-d6): δ [ppm] = 168.2; 167.9; 166.7; 148.1; 147.9;
136.8; 136.1; 133.8; 129.0; 128.9; 128.4; 128.2; 126.7; 126.7; 122.1;
121.3; 118.4; 67.6; 65.7; 63.7; 62.1; 43.7; 43.6; 43.4; 43.4; 37.4; 36.9;
30.6; 24.3; 24.2; 22.6; 22.6; 21.9; 21.8; 18.8; 18.2; MS (ESI): m/z =
774.4 ([M+Na]+).
(S)-Bus-ValΨ [4Tz]Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll
(9a): N2=Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-OAll (8a, 10mg,
13 µmol) was stirred with the (S)-Bus-Val-CH (2b, 4.0mg, 20
µmol), CuSO4·5H2O (2.5mg, 10 µmol) and sodium ascorbate
(2.6mg, 13µmol) according toGP-1. Purification via preparative
RP-HPLC yielded the product as colorless solid. Yield: 6.0mg
(6.3 µmol, 48%); Analytical RP-HPLC: tR = 3.60min (Method
A1); Preparative RP-HPLC: tR = 43.4min (Method P2, 220 nm);
1H-NMR (600 MHz, DMSO-d6): δ [ppm]= 8.94 (d, 3J = 8.5Hz,
1H); 8.83 (d, 3J = 8.5Hz, 1H); 8.15 (s, 1H); 8.00 (s, 1H); 7.93 (s,
1H); 7.18–7.09 (m, 10H); 5.90 (m, 1H); 5.59 (dd, 3J = 9.5Hz,
6.2Hz, 1H); 5.55 (dd, 3J = 9.5Hz, 6.3Hz, 1H); 5.28 (d, 3J =
8.5Hz, 1H); 5.27 (dddd, 4J = 1.5Hz, 1.5Hz, 3J = 17.2Hz, 2J =
1.5Hz, 1H); 5.23 (s (br), 1H); 5.21 (dddd, 4J = 1.3Hz, 1.3Hz, 3J
= 10.5Hz, 2J = 1.4Hz, 1H); 5.06–4.99 (m, 2H); 4.70–4.64 (m,
2H); 4.12 (dd, 3J = 7.0Hz, 7.0Hz, 1H); 3.37–3.24 (m, 4H); 2.57
(m, 1H); 2.07 (m, 1H); 1.70 (m, 1H); 1.67–1.62 (m, 2H); 1.59
(m, 1H); 1.43 (m, 1H); 1.33 (m, 1H); 1.11 (s, 9H); 0.96 (d, 3J =
6.7Hz, 3H), 0.84 (d, 3J = 6.7Hz, 3H); 0.83–0.78 (m, 15H); 0.74
(d, 3J = 6.7Hz, 3H); 13C-NMR (151 MHz, DMSO-d6): δ [ppm]
= 167.8; 166.7; 166.6; 148.3; 148.1; 147.8; 136.1; 136.1; 131.8;
128.9; 128.9; 128.2; 128.2; 126.7; 126.7; 122.0; 122.0; 121.2; 118.4;
67.5; 65.7; 63.7; 63.7; 57.9; 55.7; 43.7; 43.7; 43.1; 43.4; 37.8; 37.4;
33.4; 30.6; 24.3; 24.1; 22.7; 22.5; 22.4; 21.9; 21.8; 18.8; 18.8; 18.6;
18.3; MS (ESI):m/z = 975.5 ([M+Na]+).
Boc-Ala-ValΨ [4Tz]Phe-LeuΨ [4Tz]Phe-LeuΨ [4Tz]Val-
OAll (10a): (S)-Bus-ValΨ [4Tz]Phe-LeuΨ [4Tz]Phe-
LeuΨ [4Tz]Val-OAll (9a, 5.0mg, 5.2 µmol) was dissolved in
MeOH (0.5mL) and 4M HCl in dioxane (26 µL solution) was
added. After 2 h stirring at rt the solvent was evaporated and
the free amine was dissolved in DMF. It was stirred with Boc-
Ala-OH (1.5mg, 7.9 µmol), HATU (3.0mg, 7.9 µmol), HOAt
(1.0mg, 7.3 µmol) and DIPEA (8.0 µL, 47 µmol) according to
GP-2. Purification via preparative RP-HPLC yielded the product
as colorless solid. Yield: 3.0mg (2.9 µmol, 57%); Preparative
RP-HPLC: tR = 42.5min (Method P2, 220 nm); 1H-NMR (600
MHz, DMSO-d6): δ [ppm] = 8.93 (d, 3J = 8.4Hz, 1H); 8.87 (d,
3J = 8.5Hz, 1H); 8.05 (s, 1H); 8.01 (s, 1H); 7.93 (s, 1H); 7.93 (d,
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3J = 9.1Hz, 1H); 7.18–7.08 (m, 10H); 6.93 (d, 3J = 7.7Hz, 1H);
5.90 (m, 1H); 5.59 (dd, 3J = 9.5Hz, 6.2Hz, 1H); 5.56 (dd, 3J =
9.9Hz, 5.8Hz, 1H); 5.28 (d, 3J = 8.4Hz, 1H); 5.27 (dddd, 4J =
1.5Hz, 1.5Hz, 3J = 17.2Hz, 2J = 1.5Hz, 1H); 5.22 (dddd, 4J =
1.2Hz, 1.2Hz, 3J = 10.4Hz, 2J = 1.6Hz, 1H); 5.04 (m, 1H); 5.00
(m, 1H); 4.81 (dd, 3J = 9.1Hz, 7.0Hz, 1H); 4.70–4.64 (m, 2H);
4.02 (m, 1H); 3.37–3.22 (m, 4H); 2.57 (m, 1H); 2.00 (m, 1H);
1.71 (m, 1H); 1.67–1.62 (m, 2H); 1.57 (m, 1H); 1.42 (m, 1H);
1.37 (s, 9H); 1.32 (m, 1H); 1.14 (d, 3J = 7.1Hz, 3H); 0.96 (d, 3J =
6.7Hz, 3H); 0.84 (d, 3J = 6.7Hz, 3H); 0.81–0.76 (m, 15H); 0.73
(d, 3J = 6.7Hz, 3H); 13C-NMR (151 MHz, DMSO-d6): δ [ppm]
= 172.5; 168.2; 167.2; 167.1; 154.4; 148.5; 148.2; 147.5; 136.5;
136.2; 132.4; 130.1; 129.3; 129.0; 128.6; 127.6; 127.3; 122.4; 121.8;
121.7; 118.9; 78.4; 68.1; 66.1; 64.2; 64.2; 51.2; 50.2; 44.1; 44.1; 43.9;
43.8; 38.5; 37.9; 33.1; 31.1; 29.0; 25.0; 24.4; 23.0; 23.0; 22.2; 22.2;
19.2; 18.7; 18.5; 18.4; 18.0; MS(ESI): m/z = 1042.6 ([M+Na]+);
HRMS(ESI): m/z calcd. for C54H77N13O7Na+ ([M+Na]+):
1042.5967, found: 1042.5967.
(R)-Bus-D-LeuΨ [4Tz]Val-OAll (3b): The azide N2=Val-
OAll (1a, 70mg, 0.38 mmol) was stirred with the alkyne (R)-
Bus-D-Leu-CH (2c, 41mg, 0.19 mmol), CuSO4·5H2O (24mg,
96 µmol) and sodium ascorbate (38mg, 0.19 mmol) according
toGP-1. Purification via column chromatography (DCM/MeOH
80:1, Rf = 0.18) yielded the product as yellow oil. Yield: 74mg
(0.19 mmol, 98%); 1H-NMR (500 MHz, CDCl3): δ [ppm] =
7.90 (s, 1H); 5.84 (m, 1H); 5.26 (dddd, 4J = 1.4Hz, 1.4Hz, 3J
= 17.3Hz, 2J = 1.3Hz, 1H); 5.20 (dddd, 4J = 1.2Hz, 1.2Hz, 3J
= 10.4Hz, 2J = 1.1Hz, 1H); 5.06 (d, 3J = 8.6Hz, 1H); 4.74–
4.64 (m, 2H); 4.55 (m, 1H); 3.61 (d, 3J = 6.8Hz, 1H); 2.43 (m,
1H); 1.85 (m, 1H); 1.77 (m, 1H); 1.70 (m, 1H); 1.19 (s, 9H);
0.94 (d, 3J = 6.7Hz, 3H); 0.91 (d, 3J = 6.5Hz, 3H); 0.90 (d,
3J = 6.5Hz, 3H); 0.78 (d, 3J = 6.7Hz, 3H); 13C-NMR (126
MHz, CDCl3): δ [ppm] = 168.4; 150.7; 131.0; 121.6; 119.7; 68.8;
66.5; 56.4; 51.7; 45.7; 32.4; 24.5; 23.0; 22.7; 21.7; 19.2; 18.6; MS
(ESI): m/z = 421.2 ([M+Na]+); HRMS(ESI): m/z calcd. for
C19H34N4O3SNa+ ([M+Na]+): 421.2244, found: 421.2239.
N2=Phe-D-LeuΨ [4Tz]Val-OAll (6b): (R)-Bus-D-Leu
Ψ [4Tz]Val-OAll (3b, 74mg, 0.19mol) was dissolved in MeOH
(2mL). After addition of 4M HCl in dioxane (0.14mL) the
mixture was stirred 2 h at rt. After evaporation of the solvent the
product was used for the next step without further purification.
1H-NMR (500 MHz, CDCl3): δ [ppm] = 8.45 (s, 3H); 8.13 (s,
1H); 5.89 (m, 1H); 5.33 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 17.2Hz,
2J = 1.2Hz, 1H); 5.28 (dddd, 4J = 1.2Hz, 1.2Hz, 3J = 10.3Hz,
2J = 1.0Hz, 1H); 5.14 (d, 3J = 8.4Hz, 1H); 4.72–4.61 (m, 3H);
2.50 (m, 1H); 2.00 (m, 1H); 1.92 (m, 1H); 1.50 (m, 1H); 0.99 (d,
3J = 6.7Hz, 3H); 0.90 (d, 3J = 6.5Hz, 3H); 0.89 (d, 3J = 6.5Hz,
3H); 0.81 (d, 3J = 6.7Hz, 3H). H-D-Leu[4Tz]Val-OAll·HCl
(81mg, 0.19 mmol) was stirred with the N2=Phe-OH (1b, 39mg
0.21 mmol), HATU (106mg, 0.279 mmol), HOAt (38mg, 0.28
mmol), and DIPEA (282 µL, 1.66 mmol) according to GP-2.
Purification via column chromatography (DCM/MeOH 50:1,
Rf = 0.35) yielded the product as colorless solid. Yield: 34mg
(73 µmol, 39%); 1H-NMR (500 MHz, CDCl3): δ [ppm] = 7.68
(s, 1H); 7.24–7.18 (m, 5H); 6.67 (d, 3J = 8.7Hz, 1H); 5.90 (m,
1H); 5.34 (dddd, 4J = 1.4Hz, 1.4Hz, 3J = 17.2Hz, 2J = 1.1Hz,
1H); 5.29 (dddd, 4J = 1.1Hz, 1.1Hz, 3J = 10.4Hz, 2J = 1.0Hz,
1H); 5.21 (m, 1H); 5.12 (d, 3J = 8.8Hz, 1H); 4.72–4.62 (m, 2H);
4.15 (dd, 3J = 8.1Hz, 4.2Hz, 1H); 3.29 (dd, 3J = 4.7Hz, 2J =
14.0Hz, 1H); 2.96 (dd, 3J = 8.1Hz, 2J = 14.0Hz, 1H); 2.46
(m, 1H); 1.83–1.73 (m, 2H); 1.45 (m, 1H); 1.03 (d, 3J = 6.7Hz,
3H), 0.93 (d, 3J = 6.6Hz, 3H); 0.92 (d, 3J = 6.4Hz, 3H); 0.82
(d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz, CDCl3): δ [ppm] =
168.4; 168.0; 148.1; 136.2; 131.0; 129.5; 128.8; 127.3; 120.8; 120.0;
69.0; 66.7; 65.5; 44.1; 44.0; 38.7; 32.6; 25.0; 22.7; 22.4; 19.3; 18.7;
MS(ESI): m/z = 490.2 ([M+Na]+); HRMS(ESI): m/z calcd. for
(C24H33N7O3)2Na+ ([2M+Na]+): 957.5182, found: 957.5158.
(R)-Bus-D-LeuΨ [4Tz]Phe-D-LeuΨ [4Tz]Val-OAll (7b):
N2=Phe-D-LeuΨ [4Tz]Val-OAll (6b, 34mg, 73 µmol), the
alkyne (R)-Bus-D-Leu-CH (2c, 17mg, 79 µmol), CuSO4·5H2O
(9.0mg, 36 µmol) and sodium ascorbate (14mg, 71 µmol)
were stirred according to GP-1. Purification via preparative
RP-HPLC yielded the product as colorless solid. Yield: 39mg
(56 µmol, 77%); Analytical RP-HPLC: tR = 3.60min (Method
A1); Preparative RP-HPLC: tR = 42.6min (Method P2, 220 nm);
1H-NMR (500 MHz, CDCl3): δ [ppm] = 7.72 (s, 1H); 7.69 (s,
1H); 7.22–7.20 (m, 3H); 7.09–7.08 (m, 2H); 6.84 (d, 3J = 8.1Hz,
1H); 5.90 (m, 1H); 5.34 (dd, 3J = 8.4Hz, 6.9Hz, 1H) 5.33 (dddd,
4J = 1.4Hz, 1.4Hz, 3J = 17.1Hz, 2J = 1.3Hz, 1H); 5.28 (dddd,
4J = 1.2Hz, 1.2Hz, 3J = 10.5Hz, 2J = 1.2Hz, 1H); 5.19 (m, 1H);
5.10 (d, 3J = 8.8Hz, 1H); 4.71–4.61 (m, 2H); 4.79 (m, 1H); 3.62
(s (br), 1H); 3.58 (dd, 3J = 6.9Hz, 2J = 14.0Hz, 1H); 2.96 (dd,
3J = 8.7Hz, 2J = 13.9Hz, 1H); 2.47 (m, 1H); 1.84 (m, 1H); 1.75
(m, 1H); 1.69–1.58 (m, 2H); 1.32–1.24 (m, 2H); 1.19 (s, 9H);
1.01 (d, 3J = 6.7Hz, 3H), 0.91 (d, 3J = 7.0Hz, 3H); 0.90 (d, 3J
= 6.7Hz, 3H); 0.85 (d, 3J = 6.5Hz, 3H); 0.84 (d, 3J = 6.6Hz,
3H); 0.80 (d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz, CDCl3):
δ [ppm] = 168.5; 166.8; 150.4; 148.3; 135.6; 131.1; 129.2; 128.9;
127.4; 122.3; 120.9; 119.9; 68.9; 66.7, 66.0; 56.4; 51.8; 45.2; 44.8;
43.6; 39.2; 32.6; 24.8; 24.6; 22.9; 22.8; 22.7; 22.3; 21.9; 19.3; 18.7;
MS (ESI): m/z = 705.4 ([M+Na]+); HRMS (ESI): m/z calcd. for
C35H54N8O4SNa+ ([M+Na]+): 705.38809, found: 705.38774.
N2=Phe-D-LeuΨ [4Tz]Phe-D-LeuΨ [4Tz]Val-OAll (8b):
(R)-Bus-D-LeuΨ [4Tz]Phe-D-LeuΨ [4Tz]Val-OAll (15mg, 22
µmol) was dissolved in MeOH (2mL). After addition of 4M
HCl in dioxane (11 µL solution) the mixture was stirred 2 h at
rt. After evaporation of the solvent the free amine was dissolved
in DMF and stirred with the azido N2=Phe-OH (1b, 5.0mg,
26 µmol), HATU (13mg, 34 µmol), HOAt (4.0mg, 29 µmol),
and DIPEA (34 µl, 0.20 mmol) according to GP-2. Purification
via preparative RP-HPLC yielded the product as colorless solid.
Yield: 9.0mg (12 µmol, 54%); Preparative RP-HPLC: tR =
28.2min (Method P1, 220 nm); 1H-NMR (500 MHz, DMSO-d6):
δ [ppm] = 8.96 (d, 3J = 8.6Hz, 1H); 8.53 (d, 3J = 8.7Hz, 1H);
8.16 (s, 1H); 8.01 (s, 1H); 7.32–7.18 (m, 10H); 5.87 (m, 1H);
5.61 (dd, 3J = 8.6Hz, 6.7Hz, 1H); 5.27 (d, 3J = 8.4Hz, 1H);
5.23 (dddd, 4J = 1.4Hz, 1.4Hz, 3J = 17.3Hz, 2J = 1.5Hz, 1H);
5.19 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 10.6Hz, 2J = 1.5Hz, 1H);
5.03–4.96 (m, 2H); 4.67–4.60 (m, 2H); 3.95 (dd, 3J = 7.9Hz,
6.7Hz, 1H); 3.39 (dd, 3J = 6.7Hz, 2J = 13.5Hz, 1H); 3.34 (dd,
3J = 8.2Hz, 2J = 13.5Hz, 1H); 3.07 (dd, 3J = 6.8Hz, 2J =
13.5Hz, 1H); 2.98 (dd, 3J = 8.2Hz, 2J = 13.5Hz, 1H); 2.54 (m,
1H); 1.57 (m, 2H); 1.48–1.45 (m, 2H); 1.25 (m, 1H); 1.10 (m,
1H); 0.92 (d, 3J = 6.7Hz, 3H), 0.82–0.78 (m, 9H); 0.75 (d, 3J
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= 6.5Hz, 3H); 0.72 (d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz,
DMSO-d6): δ [ppm] = 168.1; 167.9; 165.5; 148.1; 147.8; 136.6;
135.8; 133.7; 129.1; 129.1; 128.3; 128.2; 126.; 126.7; 122.0; 121.3;
118.5; 67.5; 65.7; 63.7; 62.1; 43.7; 43.6; 43.5; 43.3; 39.5; 37.0;
30.6; 24.1; 23.9; 22.7; 22.5; 21.9; 21.8; 18.8; 18.2; MS(ESI): m/z =
774.4 ([M+Na]+).
(R)-Bus-D-ValΨ [4Tz]Phe-D-LeuΨ [4Tz]Phe-D-
LeuΨ [4Tz]Val-OAll (9b): N2=Phe-D-LeuΨ [4Tz]Phe-
D-LeuΨ [4Tz]Val-OAll (8b, 24mg, 32 µmol), the alkyne
(R)-Bus-D-Val-CH (9.0mg, 45 µmol) CuSO4·5H2O (4.0mg, 16
µmol) and sodium ascorbate (6.0mg, 30 µmol) were stirred
according toGP-1. Purification via preparative RP-HPLC yielded
the product as colorless solid. Yield: 17mg (18 µmol, 56%);
Analytical RP-HPLC: tR = 3.74min (Method A1); Preparative
RP-HPLC: tR = 46.2min (Method P2, 220 nm); 1H-NMR (600
MHz, DMSO-d6): δ [ppm]= 8.90 (d, 3J = 8.6Hz, 1H); 8.85 (d, 3J
= 8.6Hz, 1H); 8.21 (s, 1H); 8.11 (s, 1H); 7.98 (s, 1H); 7.23–7.15
(m, 10H); 5.87 (m, 1H); 5.62–5.56 (m, 2H); 5.26 (d, 3J = 8.4Hz,
1H); 5.23 (dddd, 4J = 1.5Hz, 1.5Hz, 3J = 17.2Hz, 2J = 1.6Hz,
1H); 5.20 (s (br), 1H); 5.18 (dddd, 4J = 1.5Hz, 1.5Hz, 3J =
10.6Hz, 2J = 1.2Hz, 1H); 5.01–4.96 (m, 2H); 4.67–4.60 (m, 2H);
4.11 (dd, 3J = 6.5Hz, 1H); 3.39–3.27 (m, 4H); 2.52 (m, 1H); 2.05
(m, 1H); 1.57–1.54 (m, 2H); 1.54–1.47 (m, 2H); 1.24 (m, 1H);
1.17 (m, 1H); 1.12 (s, 9H); 0.91 (d, 3J = 6.7Hz, 3H); 0.82–0.78
(m, 15H); 0.75 (d, 3J = 6.7Hz, 3H); 0.72 (d, 3J = 6.7Hz, 3H);
13C-NMR (151 MHz, DMSO-d6): δ [ppm] = 167.9; 166.5; 166.5;
148.3; 148.1; 147.6; 135.8; 135.8; 131.7; 129.1; 129.0; 128.2; 128.2;
126.7; 126.7; 122.2; 122.0; 121.3; 118.; 67.5; 65.7; 63.7; 63.7; 58.3;
55.7; 43.8; 43.6; 43.5; 43.4; 38.4; 37.9; 33.3; 30.6; 24.1; 24.0; 22.7;
22.6; 22.5; 21.9; 21.8; 19.0; 18.8; 18.3; 18.2; MS(ESI): m/z = 975.5
([M+Na]+); HRMS(ESI): m/z calcd. for C35H54N8O4SNa+
([M+Na]+): 975.5362, found: 975.5332.
Boc-Ala-D-ValΨ [4Tz]Phe-D-LeuΨ [4Tz]Phe-D-
LeuΨ [4Tz]Val-OAll (10b): (R)-Bus-D-ValΨ [4Tz]Phe-D-
LeuΨ [4Tz]Phe-D-LeuΨ [4Tz]Val-OAll (9b, 23.3mg, 25.0 µmol)
is dissolved in 1mL of a 1:1 mixture of DCM and HCl (4M
in dioxane) and stirred for 2 h at rt. After complete cleavage
of the Boc-group, the free amine is evaporated to dryness. In a
second flask, Boc-Ala-OH (9.5mg, 50 µmol) and HOAt (7.5mg,
55 µmol) are dissolved in DCM (2mL, dry). After addition of
DIC (8.5 µL, 55 µmol), the mixture is stirred 5min at RT for
preactivation and is then added to the free amine, followed by
TMP (16.5 µL; 125 µmol). This solution is left stirring over
night at rt. After evaporation of the solvent, the crude product is
purified by preparative HPLC. Yield: 15.4mg (15.1 µmol, 60%);
Analytical RP-HPLC: tR = 6.60min (Method A2); 1H-NMR
(600 MHz, DMSO-d6): δ [ppm] = 8.92 (d, J = 8.6Hz, 1H), 8.89
(d, J = 8.7Hz) 8.19 (s, 1H), 8.14 (s, 1H), 8.00 (s, 1H), 7.88 (d,
J = 9.2Hz), 7.23–7.14 (m, 10H) 6.89 (d, J = 7.6Hz, 1H), 5.86
(ddt, J = 17.2, 10.6, 5.5Hz, 1H), 5.63–5.58 (m, 2H), 5.26 (d, J =
8.4Hz, 1H), 5.23 (dd, J = 17.2, 1.7Hz, 1H), 5.18 (dd, J = 10.6,
1.5Hz, 1H), 5.01–4.96 (m, 2H), 4.81 (dd, J = 9.2, 6.4Hz, 1H),
4.64 (m, 2H), 4.03 (dq, J = 7.6, 7.2Hz, 1H), 3.40–3.26 (m, 4H),
2.50 (m, 1H), 2.05–1.96 (m, 1H), 1.58–1.50 (m, 4H), 1.36 (s, 9H),
1.28–1.14 (m, 2H), 1.18 (d, J = 7.2Hz), 0.91 (d, J = 6.7Hz, 3H),
0.82–0.78 (m, 12H), 0.75 (d, J = 6.7Hz, 3H), 0.72 (d, J = 6.8Hz,
3H), 0.70 (d, J = 6.8Hz, 3H); 13C-NMR (151 MHz, DMSO-d6):
δ [ppm] = 172.77, 168.32, 166.96, 166.94, 155.42, 148.53, 148.04,
147.33, 136.27, 136.22, 132.16, 129.50, 129.48, 128.62, 127.20,
122.46, 122.28, 121.82, 118.91, 78.49, 67.96, 66.14, 64.17, 50.82,
50.38, 44.21, 44.05, 43.90, 38.81, 38.41, 32.80, 31.08, 28.63,
24.56, 24.46, 23.09, 22.97, 22.37, 22.26, 19.34,19.24, 18.84, 18.68,
18.41; HRMS (ESI): m/z calcd. for C54H78N13O
+
7 ([M+H]
+):
1020.6142, found: 1020.6126.
Boc-GlyΨ [4Tz]Val-OAll (3c): N2=Val-OAll (104mg, 0.568
mmol), the alkyne Boc-Gly-CH (2e, 100mg, 0.644 mmol),
CuSO4·5H2O (71mg, 0.29 mmol) and sodium ascorbate
(112mg, 0.565 mmol) were stirred according to GP-1.
Purification via column chromatography (PE/EE 2:1, Rf =
0.54) yielded the product as colorless solid. Yield: 138mg (0.408
mmol, 72%);[α]20D = 40.8 (c= 0.7, CHCl3);
1H-NMR (500 MHz,
CDCl3): δ [ppm] = 7.86 (s, 1H); 5.90 (m, 1H,); 5.34 (dddd, 4J =
1.5Hz, 1.5Hz, 3J = 17.2Hz, 2J = 1.2Hz, 1H); 5.29 (dddd, 4J =
1.5Hz, 1.5Hz, 3J = 10.4Hz, 2J = 1.0Hz, 1H); 5.23 (s (br), 1H);
5.12 (d, 3J = 8.6Hz, 1H); 4.71–4.64 (m, 2H); 4.42 (d, 3J = 5.3Hz,
2H); 2.49 (m, 1H); 1.43 (s, 9H); 1.02 (d, 3J = 6.7Hz, 3H); 0.83
(d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz, CDCl3): δ [ppm] =
168.3; 156.0; 145.5; 131.0; 122.0; 120.0; 80.0; 69.2; 66.8; 36.0; 32.5;
28.5; 19.3; 18.6; MS (ESI):m/z = 361.2 ([M+Na]+).
N2=Phe-GlyΨ [4Tz]Val-OAll (6c): Boc-GlyΨ [4Tz]Val-OAll
(3c, 63mg, 0.19 mmol) was dissolved in TFA (2mL) and stirred
for 12 h. After evaporation of TFA in vacuo the crude product
was used for the next step without further purification. 1H-NMR
(500 MHz, CDCl3): δ [ppm] = 8.62 (s, 3H); 8.16 (s, 1H); 5.89
(m, 1H); 5.33 (dddd, 4J = 1.4Hz, 1.4Hz, 3J = 17.2Hz, 2J =
1.3Hz, 1H); 5.27 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 10.4Hz, 2J
= 1.0Hz, 1H); 5.14 (d, 3J = 8.5Hz, 1H); 4.71–4.60 (m, 2H);
4.37 (s (br), 2H); 2.50 (m, 1H); 0.99 (d, 3J = 6.7Hz, 3H); 0.81
(d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz, CDCl3): δ [ppm] =
168.2; 161.9 (q); 140.3; 131.0; 124.2; 120.0; 116.3 (q); 69.2; 66.9;
34.8; 32.3; 19.1; 18.3. H-GlyΨ [4Tz]Val-OAll·TFA (55mg, 0.16
mmol) and the azido acid N2=Phe-OH (1b, 34mg, 0.18 mmol)
were stirred with HATU (93mg, 0.24 mmol), HOAt (33mg,
0.24 mmol) and DIPEA (0.25mL, 1.5 mmol) according to GP-
2. Purification via preparative RP-HPLC yielded the product as
colorless solid. Yield: 34mg (83 µmol, 52% over two steps);
Preparative RP-HPLC: tR = 23.8min (Method P1, 220 nm); 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 7.82 (s, 1H); 7.29–7.21 (m,
5H); 7.01 (dd, 3J = 5.2Hz, 5.2Hz, 1H); 5.91 (m, 1H); 5.35 (dddd,
4J = 1.3Hz, 1.3Hz, 3J = 17.2Hz, 2J = 1.2Hz, 1H); 5.30 (dddd,
4J = 1.2Hz, 1.2Hz, 3J = 10.4Hz, 2J = 1.1Hz, 1H); 5.13 (d, 3J =
8.6Hz, 1H); 4.72–4.64 (m, 2H); 4.56–4.48 (m, 2H); 4.19 (dd, 3J
= 8.3Hz, 4.4Hz, 1H); 3.32 (dd, 3J = 4.4Hz, 2J = 14.0Hz, 1H);
3.00 (dd, 3J = 8.3Hz, 2J = 14.0Hz, 1H); 2.49 (m, 1H); 1.03 (d,
3J = 6.7Hz, 3H); 0.85 (d, 3J = 6.7Hz, 3H); 13C-NMR (126 MHz,
CDCl3): δ [ppm]= 169.0; 168.2; 144.0; 136.1; 130.9; 129.6; 128.8;
127.4; 122.3; 120.1; 69.2; 66.8; 65.5; 38.7; 34.8; 32.5; 19.3; 18.7; MS
(ESI):m/z = 434.2 ([M+Na]+).
Boc-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-OAll (7c): N2=Phe-
GlyΨ [4Tz]Val-OAll (6c, 34mg, 83 µmol) was stirred with
Boc-Gly-CH (2e, 19mg, 0.12 mmol), CuSO4·5H2O (10mg, 0.040
mmol) and sodium ascorbate (16mg, 81 µmmol) according to
GP-1. Purification via preparative RP-HPLC yielded the product
as colorless solid. Yield: 19mg (34 µmol, 41%); Analytical
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RP-HPLC: tR = 3.04min (Method A1); Preparative RP-HPLC: tR
= 32.9min (Method P2, 220 nm); 1H-NMR (600 MHz, CDCl3):
δ [ppm]= 7.74 (s, 1H); 7.59 (s, 1H); 7.22–7.19 (m, 3H); 7.03–7.02
(m, 2H); 6.99 (dd, 3J = 5.8Hz, 5.8Hz, 1H); 5.89 (m, 1H); 5.34
(dddd, 4J = 1.5Hz, 1.5Hz, 3J = 17.2Hz, 2J = 1.4Hz, 1H); 5.29
(dddd, 4J = 1.3Hz, 1.3Hz, 3J = 10.4Hz, 2J = 1.3Hz, 1H); 5.27
(dd, 3J = 8.6Hz, 6.9Hz, 1H); 5.11 (d, 3J = 8.6Hz, 1H); 5.11
(s (br), 1H); 4.70 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 6.0Hz, 2J =
13.0Hz, 1H); 4.65 (dddd, 4J = 1.3Hz, 1.3Hz, 3J = 6.0Hz, 2J =
13.0Hz, 1H); 4.74–4.64 (m, 2H); 4.35 (m, 2H); 3.56 (dd, 3J =
6.5Hz, 2J = 13.9Hz, 1H); 3.38 (dd, 3J = 8.9Hz, 2J = 13.9Hz,
1H); 2.47 (m, 1H); 1.43 (s, 9H); 1.03 (d, 3J = 6.7Hz, 3H); 0.83
(d, 3J = 6.7Hz, 3H); 13C-NMR (151 MHz, CDCl3): δ [ppm]
= 168.4; 167.4; 155.9; 145.7; 143.9; 135.4; 131.0; 129.0; 128.9;
127.6; 122.4; 122.0; 120.1; 79.9; 69.1; 66.8; 66.3; 39.5; 36.2; 35.5;
32.6; 28.5; 19.3; 18.8; MS (ESI):m/z = 589.3 ([M+Na]+); HRMS
(ESI): m/z calcd. for C19H34N4O3SNa+ ([M+Na]+): 589.2857,
found: 589.2852.
N2=Phe-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-OAll (8c): Boc-
GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-OAll (7c, 78mg, 0.138 mmol) was
dissolved in TFA (2mL) and stirred for 18 h. After evaporation of
TFA in vacuo the free amine, the azido carboxylic acid N2=Phe-
OH (1b, 39mg, 0.21 mmol), HATU (79mg, 0.20 mmol), HOAt
(28mg, 0.21 mmol) and DIPEA (0.21mL, 1.2 mmol) were stirred
according toGP-2. Purification via preparative RP-HPLC yielded
the product as colorless solid. Yield: 38mg (59 µmol, 43%);
Preparative RP-HPLC: tR = 34.2min (Method P3, 254 nm);
1H-NMR (500 MHz, CDCl3): δ [ppm] = 7.75 (s, 1H); 7.58 (s,
1H); 7.48 (dd, 3J = 5.6Hz, 5.6Hz, 1H); 7.28–7.16 (m, 8H); 7.08
(dd, 3J = 5.1Hz, 5.1Hz, 1H); 7.03–7.01 (m, 2H); 5.88 (m, 1H);
5.38 (dd, 3J = 8.4Hz, 7.1Hz, 1H); 5.32 (dddd, 4J = 1.5Hz,
1.5Hz, 3J = 17.1Hz, 2J = 1.5Hz, 1H); 5.28 (dddd, 4J = 1.3Hz,
1.3Hz, 3J = 10.4Hz, 2J = 1.3Hz, 1H); 5.09 (d, 3J = 8.6Hz, 1H);
4.70–4.60 (m, 2H); 4.74–4.46 (m, 2H); 4.43–4.38 (m, 2H); 4.16
(dd, 3J = 8.4Hz, 4.4Hz, 1H); 3.55 (dd, 3J = 6.8Hz, 2J = 13.9Hz,
1H); 3.35 (dd, 3J = 8.7Hz, 2J = 13.9Hz, 1H); 3.29 (dd, 3J =
4.4Hz, 2J = 14.0Hz, 1H); 2.97 (dd, 3J = 8.4Hz, 2J = 14.0Hz,
1H); 2.47 (m, 1H); 1.01 (d, 3J = 6.7Hz, 3H); 0.81 (d, 3J = 6.7Hz,
3H); 13C-NMR (126 MHz, CDCl3): δ [ppm] = 169.0; 168.3;
167.4; 144.2; 143.9; 136.3; 135.3; 131.0; 129.6; 129.0; 128.9; 128.8;
127.5; 127.3; 122.8; 122.2; 120.0; 69.1; 66.8; 65.9; 65.3; 39.4; 38.6;
35.3; 34.9; 32.5; 19.3; 18.7; MS(MALDI):m/z= 640.3 ([M+H]+);
662.3 ([M+Na]+) ; 678.3 ([M+K]
+).
Boc-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-OAll
(9c): N2=Phe-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-OAll (8c, 38mg,
59 µmol) was stirred with the alkyne Boc-Gly-CH (2e, 14mg, 88
µmol), CuSO4·5H2O (7.4mg, 30 µmol) and sodium ascorbate
(11.7mg, 59.0 µmol) according to GP-1. Purification via
preparative RP-HPLC yielded the product as colorless solid.
Yield: 7.0mg (9 µmol, 15%); Analytical RP-HPLC: tR = 3.12min
(Method A1); Preparative RP-HPLC: tR = 34.0min (Method
P3, 220 nm); 1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 9.05
(dd, 3J = 5.5Hz, 5.5Hz, 1H); 8.99 (dd, 3J = 5.6Hz, 5.6Hz, 1H);
8.07 (s, 1H); 8.05 (s, 1H); 7.94 (s, 1H); 7.28 (dd, 3J = 6.0Hz,
6.0Hz, 1H); 7.22–7.14 (m, 10H); 5.90 (m, 1H); 5.67–5.57 (m,
2H); 5.31 (d, 3J = 8.2Hz, 1H); 5.28 (dddd, 4J = 1.5Hz, 1.5Hz,
3J = 17.2Hz, 2J = 1.5Hz, 1H); 5.23 (dddd, 4J = 1.4Hz, 1.4Hz,
3J = 10.5Hz, 2J = 1.4Hz, 1H); 4.70–4.62 (m, 2H); 4.41–4.34 (m,
2H); 4.33–4.26 (m, 2H); 4.14 (m, 2H); 3.41–3.30 (m, 4H); 2.55
(m, 1H); 1.30 (s, 9H); 0.95 (d, 3J = 6.7Hz, 3H); 0.77 (d, 3J =
6.7Hz, 3H); 13C-NMR (126 MHz, DMSO-d6): δ [ppm] = 167.9;
167.4; 167.3; 155.6; 145.3; 143.8; 143.6; 136.2; 136.0; 131.8; 128.9;
128.9; 128.3; 128.3; 126.8; 126.8; 123.1; 122.2; 121.9; 118.6; 77.9;
67.5; 65.8; 63.7; 63.7; 37.8; 37.6; 35.6; 34.4; 34.4; 30.7; 28.2; 18.8;
18.3; MS(ESI): m/z = 817.5 ([M+Na]+); HRMS(ESI): m/z calcd.
for C40H50N12O6Na+ ([M+Na]+): 817.3868, found: 817.3874.
Boc-Ala-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-
OAll (10c): Boc-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Phe-GlyΨ [4Tz]Val-
OAll (9c, 50mg, 63 µmol) is dissolved in 2mL of a 1:1 mixture
of DCM and HCl (4M in dioxane) and stirred for 2 h at rt. After
complete cleavage of the Boc-group, the free amine is evaporated
to dryness. In a second flask, Boc-Ala-OH (24mg, 0.13 mmol)
and HOAt (19mg, 0.14 mmol) are dissolved in DCM (5mL,
dry). After addition of DIC (22 µL, 0.14 mmol), the mixture is
stirred 5min at RT for preactivation and is then added to the
free amine, followed by TMP (42 µL, 0.32 mmol). This solution
is left stirring over night at rt. After evaporation of the solvent,
the crude product is purified by preparative HPLC. Yield: 41mg
(47 µmol, 75%); Analytic RP-HPLC: tR = 5.3min (Method A2);
1H-NMR (600 MHz, DMSO-d6): δ [ppm] = 9.04 (dd, J = 5.61,
5.57Hz, 1H), 9.00 (dd, J = 5.56, 5.43Hz, 1H), 8.26 (dd, J = 5.99,
5.93Hz, 1H), 8.08 (s, 1H), 8.04 (s, 1H), 7.94 (s, 1H), 7.25–7.08
(m, 10H), 6.91 (d, J = 7.4Hz, 1H), 5.94–5.85 (m, 1H), 5.62–5.57
(m, 2H), 5.30 (d, J = 8.4Hz, 1H), 5.28 (dd, J = 17.2, 1.7Hz, 1H),
5.23 (dd, J = 10.5, 1.6Hz, 1H), 4.70–4.62 (m, 2H), 4.41–4.24
(m, 6H), 3.97 (dq, 1H, J = 7.4, 7.2Hz), 3.42–3.27 (m, 4H) 2.54
(dqq, J = 8.4, 6.7, 6.5Hz, 1H), 1.38 (s, 9H), 1.17 (d, J = 7.2Hz,
3H), 0.94 (d, J = 6.5Hz, 3H), 0.77 (d, J = 6.7Hz, 3H); 13C-NMR
(151 MHz, DMSO-d6): δ [ppm]= 173.15, 168.33, 167.73, 155.51,
145.26, 144.25, 144.03, 136.52, 136.49, 132.21, 129.25, 128.24,
127.24, 123.49, 122.66, 122.40, 119.06, 78.44, 67.98, 66.23, 64.16,
50.13, 38.29, 38.08, 34.84, 34.83, 34.80, 31.12, 28.68, 19.26, 18.71;
HRMS (ESI): m/z calcd. for C43H56N13O
+
7 ([M+H]
+): 866.4420,
found: 866.4413.
Conformational Analysis
Molecular dynamics (MD) simulations were performed on
a compute cluster located at the Center for Biotechnology
(CeBiTec), Bielefeld University, using the CUDA accelerated
version of the pmemd program as implemented in
AMBER (Amber 16, AmberTools 17) (Case et al., 2017).
All simulations were based on the additional force-field
TZLff (Marion et al., 2018) parametrized for 1,4- and 1,5-
disubstituted peptidotriazolamers.
Identical simulation strategies were applied for the
conformational analysis of all molecules. First, 100 parallel
simulated annealing (SA) runs were performed in the gas
phase by applying NMR-derived inter-proton restraints
(Supplementary Tables 1–3). No cutoff was applied on non-
bonded interactions and the temperature ramp was set to
gradually heat up the molecule from 0 to 600K and finally cool
it down to 0K over a 1 ns-long MD run(10K, 5 ps; 100K, 5 ps;
200K, 90 ps; 600K, 400 ps; 400K, 100 ps; 200K, 200 ps; 100K, 75
ps; 10K, 20 ps; 0 K, 5 ps). Interproton distances were calculated
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from ROESY-NMR spectra using equation 3 by Ämmälahti
et al. (1996). The harmonic restraints were applied only to the
upper bound, with a force constant of 32 kcal·mol−1·Å−2 (as
set in the input of AMBER). After an initial series of 100 runs,
NMR restraint restraints causing penalties <5 kcal·mol−1, were
regarded as potential artifacts from the spectrum interpretation
and removed from the set of restraints. The procedure was then
repeated until no restraint passed the penalty ceiling.
The representative structure of the main cluster (based on
backbone atoms only) among the SA replica was further selected
as a starting structure for MD simulations in solvent. Each
molecule was solvated in a truncated octaedron box of (i)
TIP4Pew water (Horn et al., 2004) molecules and (ii) DMSO
(Fox and Kollman, 1998) molecules, the solvent used for NMR,
with a 15 Å buffer region. After minimization, the systems were
gradually heated up, first in the NVT ensemble from 0 to 100K,
and then in the NPT ensemble from 100 to 300K over a total
of 890 ps (10K, 10 ps; 50K, 10 ps; 100K, 20 ps; 100K, 50 ps;
200K, 100 ps; 300K, 200 ps; 300K, 500 ps). Production runs were
then performed in the NPT ensemble for 200 ns. All simulations
of solvated systems used a time step of 2 fs, periodic boundary
conditions with particle mesh Ewald and a non-bonded cutoff
of 12 Å, and the SHAKE algorithm to constrain the length of
all bonds involving a hydrogen atom. Temperature and pressure
were controlled with Langevin dynamics (collision frequency of
2.0 ps−1) and isotropic position scaling, respectively. For each
system, one simulation in water and one simulation in DMSO
were performed without applying any NMR restraint.
The simulations for the longer poly-alanine mimics (poly-
Ala) followed the same protocol and were performed without
restraints in water and in DMSO. For each poly-Ala system, four
parallel simulations were ran starting from the same coordinates
after heatup but with different initial velocities in order to
increase the sampling of the conformational space and ensure
convergence of our analysis.
Analysis of the trajectories were performed using cpptraj
module of AmberTools17 (Roe and Cheatham, 2013). The
output data was post processed using python 2 including
NumPy and matplotlib modules (Hunter, 2007; Oliphant, 2007).
Cluster analysis was performed using cpptraj’s hierarchical
agglomerative approach with a total of 10 clusters based on
backbone RMSD (N, CO, Cα, Ψ [4Tz]). Root mean square
deviation (RMSD) and radius of gyration (RoG) analysis were
performed based on backbone atoms only (N, CO, Cα, Ψ [4Tz])
using the heatup structure as reference point in the case of
RMSD. Dihedral analysis was done using the φ- and ψ- torsion
angles defined in Figure 4. The torsion angle distribution was
plotted in a Ramachandran like style using matplotlib. Radial
distribution functions (RDFs) were calculated using a bin spacing
of 0.1 Å and normalized using the default density of water
as implemented in cpptraj. The representative structures of
the main clusters were prepared using the VMD software
(Humphrey et al., 1996).
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